Here's Why Dynavax Is Surging 6.1% Today

Dynavax's (NASDAQ: DVAX) shares are climbing 6.1% as of 3:35 p.m. EDT on Tuesday after the company announced the first patients have been dosed in an early stage trial evaluating a COVID-19 vaccine containing its CpG 1018 adjuvant.

Medicago, a private company owned by Mitsubishi Tanabe Pharma (OTC: MTZXF) and Philip Morris International (NYSE: PM), is evaluating whether Dynavax's adjuvant enhances immune responses to its plant-derived COVID-19 vaccine.

Image source: Getty Images.

Continue reading

Source Fool.com